These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17295029)

  • 1. Thrombotic microangiopathy and intravenous immunoglobulin therapy.
    Watanabe T
    Pediatr Nephrol; 2007 Jun; 22(6):907-8; author reply 909. PubMed ID: 17295029
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous gamma globulin for thrombotic microangiopathy of unknown etiology.
    Ito S; Okuyama K; Nakamura T; Tetanishi J; Saito K; Matsumoto M; Fujimura Y; Aihara Y; Yokota S
    Pediatr Nephrol; 2007 Feb; 22(2):301-5. PubMed ID: 17058049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Foot manifestations of the thrombotic thrombocytopenic purpura hemolytic-uremic syndrome: a review and case report.
    Bibbo C; Davis WH
    J Foot Ankle Surg; 2005; 44(4):301-6. PubMed ID: 16012439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New aspects in the pathogenesis and treatment of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
    Raife T; Montgomery R
    Rev Clin Exp Hematol; 2001 Sep; 5(3):236-61; discussion 311-2. PubMed ID: 11703817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombotic microangiopathy in the cancer patient.
    Kwaan HC; Gordon LI
    Acta Haematol; 2001; 106(1-2):52-6. PubMed ID: 11549777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombotic microangiopathy in an allograft kidney: a diagnostic challenge.
    Chan GS; Tse KC; Lam MF; Chan KW
    Histopathology; 2006 May; 48(6):775-6. PubMed ID: 16681703
    [No Abstract]   [Full Text] [Related]  

  • 7. [Renal pathology of thromobotic microangiopathy].
    Mii A; Shimizu A
    Nihon Jinzo Gakkai Shi; 2014; 56(7):1031-42. PubMed ID: 25420403
    [No Abstract]   [Full Text] [Related]  

  • 8. Catastrophic presentation of a patient with combined NMOSD and thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: a case report.
    Okhovat AA; Ansari B; Rezaali S; Altintas A; Naser Moghadasi A
    Acta Neurol Belg; 2017 Sep; 117(3):757-759. PubMed ID: 27757811
    [No Abstract]   [Full Text] [Related]  

  • 9. Thrombotic microangiopathy after allogeneic bone marrow transplantation: a pathologic abnormality associated with diverse clinical syndromes.
    George JN; Selby GB
    Bone Marrow Transplant; 2004 Jun; 33(11):1073-4. PubMed ID: 15153944
    [No Abstract]   [Full Text] [Related]  

  • 10. Thrombotic microangiopathies: renal and extrarenal lesions.
    Droz D; Nochy D; Noël LH; Heudes D; Nabarra B; Hill GS
    Adv Nephrol Necker Hosp; 2000; 30():235-59. PubMed ID: 11068646
    [No Abstract]   [Full Text] [Related]  

  • 11. [Intravenous immunoglobulin therapy for kidney diseases in children].
    Zwolińska D
    Pol Merkur Lekarski; 2011 Jun; 30(180):423-6. PubMed ID: 21751552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inefficacy of intravenous immunoglobulin in patients with low-risk thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome.
    Finazzi G; Bellavita P; Falanga A; Viero P; Barbui T
    Am J Hematol; 1992 Nov; 41(3):165-9. PubMed ID: 1415190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there a shared pathophysiology for thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome?
    Desch K; Motto D
    J Am Soc Nephrol; 2007 Sep; 18(9):2457-60. PubMed ID: 17687074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thrombotic thrombocytopenic purpura and other microangiopathies: kidneys at risk!].
    MMW Fortschr Med; 2009 Apr; 151(14):14. PubMed ID: 19504834
    [No Abstract]   [Full Text] [Related]  

  • 15. Noncardiogenic pulmonary edema triggered by intravenous immunoglobulin in cancer-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
    Suassuna JH; da Costa MA; Faria RA; Melichar AC
    Nephron; 1997; 77(3):368-70. PubMed ID: 9375839
    [No Abstract]   [Full Text] [Related]  

  • 16. No common final pathogenetic pathway in haemolytic uraemic syndromes.
    Taylor CM; Howie AJ; Williams JM
    Nephrol Dial Transplant; 1999 May; 14(5):1100-2. PubMed ID: 10344345
    [No Abstract]   [Full Text] [Related]  

  • 17. Hemolytic uremic syndrome/thrombotic thrombocytopenic purpura (HUS/TTP) complicating adult Still's disease: remission induced with intravenous immunoglobulin G.
    Diamond JR
    J Nephrol; 1997; 10(5):253-7. PubMed ID: 9364316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thrombotic microangiopathy (TMA) (1). TMA in the target organs of graft-versus-host disease].
    Hirabayashi N
    Rinsho Ketsueki; 2000 Jun; 41(6):491-5. PubMed ID: 10921348
    [No Abstract]   [Full Text] [Related]  

  • 19. Thrombotic microangiopathy.
    Kwaan HC
    Adv Exp Med Biol; 1990; 281():367-75. PubMed ID: 2102622
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hemolytic uremic syndrome and thrombotic thrombocytopenic purpura. Current perspectives on EHEC, complement mutations and ADAMTS13].
    Karpman D
    Lakartidningen; 2008 Apr 9-15; 105(15):1096-101. PubMed ID: 18561752
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.